PUBLISHER: The Insight Partners | PRODUCT CODE: 1688920

PUBLISHER: The Insight Partners | PRODUCT CODE: 1688920

Soft Tissue Allografts Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, End User, and Geography

PUBLISHED: March 6, 2025

PAGES: 165 Pages

DELIVERY TIME: 1-5 business days

SELECT AN OPTION

The Soft Tissue Allografts market is anticipated to grow from US$ 4.08 billion in 2024 and is projected to reach US$ 6.74 billion by 2031; it is expected to register a CAGR of 7.4% during 2025-2031. Increasing aging population and the rising incidence of sports injuries & trauma are contributing to the growing soft tissue allografts market size. However, the high cost of procedures hampers the soft tissue allografts market growth. Further, development of customized grafts is expected to bring in new soft tissue allografts market trends in the coming years.

In terms of revenue, North America dominated the market in 2024. It is estimated to dominate the global market during the forecast period. The US is the largest market for soft tissue allografts in the world.

Sports injuries often lead to ailments such as joint pain, stiffness, and swelling. As per the data published by Johns Hopkins, there has been a significant rise in the number of participants in organized sports activities over the years. Approximately 30 million children and adolescents participate in youth sports in the country, leading to an increase in the number of sports injuries among young athletes, with over 3.5 million injuries reported yearly. Almost one-third of all injuries that occur in childhood are caused by sports. According to the National Safety Council (NSC), biking caused 426,000 injuries in 2020, the most of any sport or recreational activity, while exercises (with or without equipment) ranked second with ~378,000 injuries. These factors were followed by off-highway vehicles (OHVs, including mopeds and minibikes) with 230,000 injuries, and skateboards, scooters, and hoverboards with 218,000 injuries. Sports-related injuries often involve damage to soft tissues such as muscles, tendons, and ligaments. These injuries range from strains and sprains to more severe conditions such as tears or ruptures. In some cases, when the injury is too extensive for the body to heal on its own, soft tissue allografts are used to repair or reconstruct the damaged tissue. These allografts are particularly useful for repairing ligaments, tendons, or cartilages that are too damaged to treat via other methods such as sutures or autografts (using patient's self-tissue).

The US represents a significant portion of the soft tissue allografts market, with a notable number of procedures performed annually. According to a study titled "New Device Inspired by Python Teeth Doubles Strength of Rotator Cuff," published in 2024, more than 600,000 rotator cuff procedures are performed yearly in the US. As per the American Orthopedic Society for Sports Medicine, nearly 100,000 to 250,000 ACL ruptures are reported in the country annually. Several tissue injuries have received significant importance, increasing awareness about soft tissue injuries and their treatment among athletes.

Furthermore, in May 2023, AlloSource announced the introduction of AlloMend Duo Acellular Dermal Matrix (ADM), a natural solution designed for soft tissue reconstruction. It is one of the largest nonprofit providers of allografts in the US, known for developing innovative cellular and tissue products to aid surgeons in healing their patients. ADM was developed to assist surgeons in repairing and reconstructing soft tissue defects, offering long-term structural support. This deep reticular dermal allograft integrates with the surrounding tissue, serving as a scaffold that encourages cell repopulation and regeneration of natural host tissues. Its flexible and pliable characteristics make it ideal for various medical procedures that demand strength and biocompatibility in a human regenerative tissue matrix, allowing for precision placement and optimal handling.

Soft Tissue Allografts Market Analysis

New Product Launches to Provide Market Opportunities in Future

Several companies are focusing on developing innovative products through extensive research. These products are likely to offer superior treatment outcomes compared to the existing products. For instance, AlloSource is one of the largest allograft providers in the US, offering innovative cellular and tissue products to help healthcare providers heal their patients. In May 2023, the company announced the launch of AlloMend Duo Acellular Dermal Matrix (ADM), a natural solution for soft tissue reconstruction. In June 2024, Axogen, Inc., a global leader in developing innovative surgical solutions for peripheral nerve injuries, announced the launch of its new product named Avive+ Soft Tissue Matrix. This product is intended for use as a soft tissue barrier; it is a resorbable, multi-layer amniotic membrane allograft designed to provide temporary protection and tissue separation during the critical phase of peripheral nerve healing. In February 2022, Amnio Technology, a global leader in amniotic tissue allograft development and distribution, announced the launch of two new products in its PalinGen membrane line: the PalinGen Dual-Layer Membrane and the Dual Layer PalinGen X-Membrane. Similar to all products in the PalinGen family, these new allografts are minimally modified and are intended for homologous use. The new soft tissue allograft products launched in recent years are designed to meet changing patient needs, improve recovery times, reduce complications, and address various clinical indications. Launching more such products is expected to create significant growth opportunities for the soft tissue allograft market in the coming years.

Soft Tissue Allografts Market Report Segmentation Analysis

Key segments that contributed to the derivation of the soft tissue allografts market analysis are type, application, and end user.

Based on type, the soft tissue allografts market is segmented into cartilage allograft, tendon allograft, dental allograft, meniscus allografts, placental tissue, and others. The cartilage allograft segment held the largest share of the market in 2024.

In terms of application, the soft tissue allografts market is categorized into orthopedic, dentistry, wound care, and others. The orthopedic segment dominated the market in 2024.

In terms of end user, the soft tissue allografts market is categorized into hospitals, specialty clinics, and others. The hospitals segment dominated the market in 2024.

Soft Tissue Allografts Market: Competitive Landscape and Key Developments

Zimmer Biomet Holdings Inc, Conmed Corp, Stryker Corp, Smith & Nephew Plc, Integra LifeSciences Holdings Corp, Arthrex Inc, AbbVie Inc, Organogenesis Inc., Dentsply Sirona Inc, and Axogen Corporation are among the key companies operating in the soft tissue allografts market.

The National Health Service (NHS), American Academy of Orthopaedic Surgeons (AAOS), World Health Organization, US Department of Health and Human Services, and National Safety Council are among the primary and secondary sources referred to while preparing the soft tissue allografts market report.

Product Code: TIPRE00025025

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Soft Tissue Allografts Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Soft Tissue Allografts Market - Key Market Dynamics

5.1 Soft Tissue Allografts Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Aging Population
- 5.2.2 Rising Incidence of Sports Injuries and Trauma
5.3 Key Market Restraints
- 5.3.1 High Cost of Procedures
5.4 Key Market Opportunities
- 5.4.1 New Product Launches
5.5 Future Trends
- 5.5.1 Development of Customized Grafts
5.6 Impact of Drivers and Restraints:

6. Soft Tissue Allografts Market - Global Market Analysis

6.1 Soft Tissue Allografts Market Revenue (US$ Million), 2021-2031
6.2 Soft Tissue Allografts Market Forecast Analysis

7. Soft Tissue Allografts Market Analysis - by Type

7.1 Cartilage Allograft
- 7.1.1 Overview
- 7.1.2 Cartilage Allograft: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Tendon Allograft
- 7.2.1 Overview
- 7.2.2 Tendon Allograft: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Dental Allografts
- 7.3.1 Overview
- 7.3.2 Dental Allografts: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Meniscus Allografts
- 7.4.1 Overview
- 7.4.2 Meniscus Allografts: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Placental Tissue
- 7.5.1 Overview
- 7.5.2 Placental Tissue: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)

8. Soft Tissue Allografts Market Analysis - by Application

8.1 Orthopedic
- 8.1.1 Overview
- 8.1.2 Orthopedic: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Dentistry
- 8.2.1 Overview
- 8.2.2 Dentistry: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Wound Care
- 8.3.1 Overview
- 8.3.2 Wound Care: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Others
- 8.4.1 Overview
- 8.4.2 Others: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)

9. Soft Tissue Allografts Market Analysis - by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Specialty Clinics
- 9.2.1 Overview
- 9.2.2 Specialty Clinics: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Others
- 9.3.1 Overview
- 9.3.2 Others: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)

10. Soft Tissue Allografts Market - Geographical Analysis

10.1 Overview
10.2 North America
- 10.2.1 North America Soft Tissue Allografts Market Overview
- 10.2.2 North America: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
  - 10.2.2.1 North America: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by Type
  - 10.2.2.2 North America: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by Application
  - 10.2.2.3 North America: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by End User
- 10.2.3 North America: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by Country
  - 10.2.3.1 North America: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by Country
  - 10.2.3.2 United States: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.2.1 United States: Soft Tissue Allografts Market Breakdown, by Type
    - 10.2.3.2.2 United States: Soft Tissue Allografts Market Breakdown, by Application
    - 10.2.3.2.3 United States: Soft Tissue Allografts Market Breakdown, by End User
  - 10.2.3.3 Canada: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.3.1 Canada: Soft Tissue Allografts Market Breakdown, by Type
    - 10.2.3.3.2 Canada: Soft Tissue Allografts Market Breakdown, by Application
    - 10.2.3.3.3 Canada: Soft Tissue Allografts Market Breakdown, by End User
  - 10.2.3.4 Mexico: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.2.3.4.1 Mexico: Soft Tissue Allografts Market Breakdown, by Type
    - 10.2.3.4.2 Mexico: Soft Tissue Allografts Market Breakdown, by Application
    - 10.2.3.4.3 Mexico: Soft Tissue Allografts Market Breakdown, by End User
10.3 Europe
- 10.3.1 Europe Soft Tissue Allografts Market Overview
- 10.3.2 Europe: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
  - 10.3.2.1 Europe: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by Type
  - 10.3.2.2 Europe: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by Application
  - 10.3.2.3 Europe: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by End User
- 10.3.3 Europe: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by Country
  - 10.3.3.1 Europe: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by Country
  - 10.3.3.2 Germany: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.2.1 Germany: Soft Tissue Allografts Market Breakdown, by Type
    - 10.3.3.2.2 Germany: Soft Tissue Allografts Market Breakdown, by Application
    - 10.3.3.2.3 Germany: Soft Tissue Allografts Market Breakdown, by End User
  - 10.3.3.3 United Kingdom: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.3.1 United Kingdom: Soft Tissue Allografts Market Breakdown, by Type
    - 10.3.3.3.2 United Kingdom: Soft Tissue Allografts Market Breakdown, by Application
    - 10.3.3.3.3 United Kingdom: Soft Tissue Allografts Market Breakdown, by End User
  - 10.3.3.4 France: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.4.1 France: Soft Tissue Allografts Market Breakdown, by Type
    - 10.3.3.4.2 France: Soft Tissue Allografts Market Breakdown, by Application
    - 10.3.3.4.3 France: Soft Tissue Allografts Market Breakdown, by End User
  - 10.3.3.5 Spain: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.5.1 Spain: Soft Tissue Allografts Market Breakdown, by Type
    - 10.3.3.5.2 Spain: Soft Tissue Allografts Market Breakdown, by Application
    - 10.3.3.5.3 Spain: Soft Tissue Allografts Market Breakdown, by End User
  - 10.3.3.6 Italy: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.6.1 Italy: Soft Tissue Allografts Market Breakdown, by Type
    - 10.3.3.6.2 Italy: Soft Tissue Allografts Market Breakdown, by Application
    - 10.3.3.6.3 Italy: Soft Tissue Allografts Market Breakdown, by End User
  - 10.3.3.7 Rest of Europe: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.3.3.7.1 Rest of Europe: Soft Tissue Allografts Market Breakdown, by Type
    - 10.3.3.7.2 Rest of Europe: Soft Tissue Allografts Market Breakdown, by Application
    - 10.3.3.7.3 Rest of Europe: Soft Tissue Allografts Market Breakdown, by End User
10.4 Asia Pacific
- 10.4.1 Asia Pacific Soft Tissue Allografts Market Overview
- 10.4.2 Asia Pacific: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
  - 10.4.2.1 Asia Pacific: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by Type
  - 10.4.2.2 Asia Pacific: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by Application
  - 10.4.2.3 Asia Pacific: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by End User
- 10.4.3 Asia Pacific: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by Country
  - 10.4.3.1 Asia Pacific: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by Country
  - 10.4.3.2 China: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.3.2.1 China: Soft Tissue Allografts Market Breakdown, by Type
    - 10.4.3.2.2 China: Soft Tissue Allografts Market Breakdown, by Application
    - 10.4.3.2.3 China: Soft Tissue Allografts Market Breakdown, by End User
  - 10.4.3.3 Japan: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.3.3.1 Japan: Soft Tissue Allografts Market Breakdown, by Type
    - 10.4.3.3.2 Japan: Soft Tissue Allografts Market Breakdown, by Application
    - 10.4.3.3.3 Japan: Soft Tissue Allografts Market Breakdown, by End User
  - 10.4.3.4 India: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.3.4.1 India: Soft Tissue Allografts Market Breakdown, by Type
    - 10.4.3.4.2 India: Soft Tissue Allografts Market Breakdown, by Application
    - 10.4.3.4.3 India: Soft Tissue Allografts Market Breakdown, by End User
  - 10.4.3.5 Australia: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.3.5.1 Australia: Soft Tissue Allografts Market Breakdown, by Type
    - 10.4.3.5.2 Australia: Soft Tissue Allografts Market Breakdown, by Application
    - 10.4.3.5.3 Australia: Soft Tissue Allografts Market Breakdown, by End User
  - 10.4.3.6 South Korea: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.3.6.1 South Korea: Soft Tissue Allografts Market Breakdown, by Type
    - 10.4.3.6.2 South Korea: Soft Tissue Allografts Market Breakdown, by Application
    - 10.4.3.6.3 South Korea: Soft Tissue Allografts Market Breakdown, by End User
  - 10.4.3.7 Rest of APAC: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.4.3.7.1 Rest of APAC: Soft Tissue Allografts Market Breakdown, by Type
    - 10.4.3.7.2 Rest of APAC: Soft Tissue Allografts Market Breakdown, by Application
    - 10.4.3.7.3 Rest of APAC: Soft Tissue Allografts Market Breakdown, by End User
10.5 Middle East and Africa
- 10.5.1 Middle East and Africa Soft Tissue Allografts Market Overview
- 10.5.2 Middle East and Africa: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
  - 10.5.2.1 Middle East and Africa: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by Type
  - 10.5.2.2 Middle East and Africa: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by Application
  - 10.5.2.3 Middle East and Africa: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by End User
- 10.5.3 Middle East and Africa: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by Country
  - 10.5.3.1 Middle East and Africa: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by Country
  - 10.5.3.2 Saudi Arabia: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.3.2.1 Saudi Arabia: Soft Tissue Allografts Market Breakdown, by Type
    - 10.5.3.2.2 Saudi Arabia: Soft Tissue Allografts Market Breakdown, by Application
    - 10.5.3.2.3 Saudi Arabia: Soft Tissue Allografts Market Breakdown, by End User
  - 10.5.3.3 South Africa: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.3.3.1 South Africa: Soft Tissue Allografts Market Breakdown, by Type
    - 10.5.3.3.2 South Africa: Soft Tissue Allografts Market Breakdown, by Application
    - 10.5.3.3.3 South Africa: Soft Tissue Allografts Market Breakdown, by End User
  - 10.5.3.4 United Arab Emirates: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.3.4.1 United Arab Emirates: Soft Tissue Allografts Market Breakdown, by Type
    - 10.5.3.4.2 United Arab Emirates: Soft Tissue Allografts Market Breakdown, by Application
    - 10.5.3.4.3 United Arab Emirates: Soft Tissue Allografts Market Breakdown, by End User
  - 10.5.3.5 Rest of Middle East and Africa: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.5.3.5.1 Rest of Middle East and Africa: Soft Tissue Allografts Market Breakdown, by Type
    - 10.5.3.5.2 Rest of Middle East and Africa: Soft Tissue Allografts Market Breakdown, by Application
    - 10.5.3.5.3 Rest of Middle East and Africa: Soft Tissue Allografts Market Breakdown, by End User
10.6 South and Central America
- 10.6.1 South and Central America Soft Tissue Allografts Market Overview
- 10.6.2 South and Central America: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
  - 10.6.2.1 South and Central America: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by Type
  - 10.6.2.2 South and Central America: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by Application
  - 10.6.2.3 South and Central America: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by End User
- 10.6.3 South and Central America: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by Country
  - 10.6.3.1 South and Central America: Soft Tissue Allografts Market - Revenue and Forecast Analysis - by Country
  - 10.6.3.2 Brazil: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.6.3.2.1 Brazil: Soft Tissue Allografts Market Breakdown, by Type
    - 10.6.3.2.2 Brazil: Soft Tissue Allografts Market Breakdown, by Application
    - 10.6.3.2.3 Brazil: Soft Tissue Allografts Market Breakdown, by End User
  - 10.6.3.3 Argentina: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.6.3.3.1 Argentina: Soft Tissue Allografts Market Breakdown, by Type
    - 10.6.3.3.2 Argentina: Soft Tissue Allografts Market Breakdown, by Application
    - 10.6.3.3.3 Argentina: Soft Tissue Allografts Market Breakdown, by End User
  - 10.6.3.4 Rest of South and Central America: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.6.3.4.1 Rest of South and Central America: Soft Tissue Allografts Market Breakdown, by Type
    - 10.6.3.4.2 Rest of South and Central America: Soft Tissue Allografts Market Breakdown, by Application
    - 10.6.3.4.3 Rest of South and Central America: Soft Tissue Allografts Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 New Product Development
11.3 Merger and Acquisition
11.4 Partnerships

12. Company Profiles

12.1 Zimmer Biomet Holdings Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Conmed Corp
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Stryker Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Smith & Nephew Plc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Integra LifeSciences Holdings Corp
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Arthrex Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 AbbVie Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Organogenesis Inc.
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Dentsply Sirona Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Axogen Corporation
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

Product Code: TIPRE00025025

List Of Tables

Table 1. Soft Tissue Allografts Market Segmentation
Table 2. Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Table 3. Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million) - by Type
Table 4. Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 5. Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 6. North America: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 7. North America: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 8. North America: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 9. North America: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 10. United States: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 11. United States: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 12. United States: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 13. Canada: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 14. Canada: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 15. Canada: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 16. Mexico: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 17. Mexico: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 18. Mexico: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 19. Europe: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 20. Europe: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 21. Europe: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 22. Europe: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 23. Germany: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 24. Germany: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 25. Germany: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 26. United Kingdom: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 27. United Kingdom: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 28. United Kingdom: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 29. France: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 30. France: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 31. France: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 32. Spain: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 33. Spain: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 34. Spain: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 35. Italy: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 36. Italy: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 37. Italy: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 38. Rest of Europe: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 39. Rest of Europe: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 40. Rest of Europe: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 41. Asia Pacific: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 42. Asia Pacific: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 43. Asia Pacific: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 44. Asia Pacific: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 45. China: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 46. China: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 47. China: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 48. Japan: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 49. Japan: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 50. Japan: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 51. India: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 52. India: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 53. India: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 54. Australia: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 55. Australia: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 56. Australia: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 57. South Korea: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 58. South Korea: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 59. South Korea: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 60. Rest of APAC: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 61. Rest of APAC: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 62. Rest of APAC: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 63. Middle East and Africa: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 64. Middle East and Africa: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 65. Middle East and Africa: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 66. Middle East and Africa: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 67. Saudi Arabia: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 68. Saudi Arabia: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 69. Saudi Arabia: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 70. South Africa: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 71. South Africa: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 72. South Africa: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 73. United Arab Emirates: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 74. United Arab Emirates: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 75. United Arab Emirates: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 76. Rest of Middle East and Africa: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 77. Rest of Middle East and Africa: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 78. Rest of Middle East and Africa: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 79. South and Central America: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 80. South and Central America: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 81. South and Central America: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 82. South and Central America: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Country
Table 83. Brazil: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 84. Brazil: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 85. Brazil: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 86. Argentina: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 87. Argentina: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 88. Argentina: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 89. Rest of South and Central America: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Type
Table 90. Rest of South and Central America: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 91. Rest of South and Central America: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 92. Glossary of Terms, Soft Tissue Allografts Market

List Of Figures

Figure 1. Soft Tissue Allografts Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Soft Tissue Allografts Market Revenue (US$ Million), 2021-2031
Figure 5. Soft Tissue Allografts Market Share (%) - by Type (2024 and 2031)
Figure 6. Cartilage Allograft: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Tendon Allograft: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Dental Allografts: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Meniscus Allografts: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Placental Tissue: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Others: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Soft Tissue Allografts Market Share (%) - by Application (2024 and 2031)
Figure 13. Orthopedic: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Dentistry: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Wound Care: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Others: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Soft Tissue Allografts Market Share (%) - by End User (2024 and 2031)
Figure 18. Hospitals: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Specialty Clinics: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Others: Soft Tissue Allografts Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Soft Tissue Allografts Market Breakdown by Region, 2024 and 2031 (%)
Figure 22. North America: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 23. North America: Soft Tissue Allografts Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 24. United States: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 25. Canada: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 26. Mexico: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 27. Europe: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 28. Europe: Soft Tissue Allografts Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 29. Germany: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 30. United Kingdom: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 31. France: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 32. Spain: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 33. Italy: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 34. Rest of Europe: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 35. Asia Pacific: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 36. Asia Pacific: Soft Tissue Allografts Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 37. China: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 38. Japan: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 39. India: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 40. Australia: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 41. South Korea: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 42. Rest of APAC: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 43. Middle East and Africa: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 44. Middle East and Africa: Soft Tissue Allografts Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 45. Saudi Arabia: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 46. South Africa: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 47. United Arab Emirates: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 48. Rest of Middle East and Africa: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 49. South and Central America: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 50. South and Central America: Soft Tissue Allografts Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 51. Brazil: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 52. Argentina: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)
Figure 53. Rest of South and Central America: Soft Tissue Allografts Market - Revenue and Forecast to 2031(US$ Million)

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ